Furthermore, APP, beta-site amyloid precursor protein cleaving enzyme (BACE), and presenilin-1 (PSEN1) gene mutations are common in AD patients, and similar promoter mutations have different clinical manifestations in some cases. Here, PSEN1 is linked to Alzheimer disease.